NHS National Framework for low molecular weight heparin products and fondaparinux
NHS National Framework for low molecular weight heparin products and fondaparinux Offer reference number: CM/PHR/22/5687 Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Buyer
NHS England
Value
£153,070,000
Published
31 Mar 2023
Closes
3 May 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Framework for low molecular weight heparin products and fondaparinux
£153,070,000
NHS National Framework for low molecular weight heparin products and fondaparinux Offer reference number: CM/PHR/22/5687 Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
29 Mar 2023
Opportunity notice on Contracts Finder
Tender notice · Web page
Document No. 04a - Quality Assurance Process - CM-PHR-22-5687
Not provided
Document No. 04a - Quality Assurance Process - CM-PHR-22-5687
Document No. 05a - Selectt Offer File CM_PHR_22_5687_01
Not provided
Document No. 05a - Selectt Offer File CM_PHR_22_5687_01
XML
Document No. 05b - Tender Product Listing and Usage
Not provided
Document No. 05b - Tender Product Listing and Usage
Excel spreadsheet
Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5687
Not provided
Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5687
Word document
Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHR-22-5687
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHR-22-5687
Word document
Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM-PHR-22-5687
Not provided
Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM-PHR-22-5687
Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5687
Not provided
Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5687
Word document
Document No. 02 - Terms of offer - CM-PHR-22-5687
Not provided
Document No. 02 - Terms of offer - CM-PHR-22-5687
Word document
Document No. 06 - Form of offer - CM-PHR-22-5687
Not provided
Document No. 06 - Form of offer - CM-PHR-22-5687
Word document
Document No. 07a - Quality control technical sheet - CM-PHR-22-5687
Not provided
Document No. 07a - Quality control technical sheet - CM-PHR-22-5687
Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022
Not provided
Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022
Contains public sector information licensed under the Open Government Licence v3.0.